United States Pharmaceuticals

Prestige Consumer Healthcare Inc (PBH)

Track

Over the past 90 days, Prestige Consumer Healthcare Inc. has seen insider trading activity characterized exclusively by sales. Senior VP of Operations Jeffrey Zerillo executed multiple sell transactions during this period. These divestments occurred against a backdrop of relatively stable stock performance, with the share price currently trading at approximately 34% of its 52-week range.
Ticker: PBH Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Prestige Consumer Healthcare Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 11 May 2026
Value US$2,713,510.69 | Price 383.46 | Shares 19,060 (-29.4%)
Proposed sale 11 May 2026
Value US$3,519,101.63 | Price 61.90 | Shares 67,577
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-12 2026-05-11 S Sale
3.5
Zerillo Jeffrey

Senior VP Operations

Officer
19,060 -29.4%
383.46
US$2,713,511 		19,060 -29.4% 383.46 US$2,713,511
2026-05-11 2026-05-11 PrS Proposed sale
3.5
Zerillo Jeffrey

Officer

Officer
67,577
61.90
US$3,519,102 		67,577 61.90 US$3,519,102
2026-05-11 2026-05-07 S Sale
3.5
Zerillo Jeffrey

Senior VP Operations

Officer
66,492 +8.9%
210.12
US$4,186,072 		66,492 +8.9% 210.12 US$4,186,072
2026-05-07 2026-05-07 PrS Proposed sale
3.5
Zerillo Jeffrey

Officer

Officer
305
54.36
US$16,580 		305 54.36 US$16,580
2026-05-06 2026-05-06 PrS Proposed sale
3.5
Zerillo Jeffrey

Officer

Officer
1,207
54.99
US$66,374 		1,207 54.99 US$66,374
2026-05-07 2026-05-05 S Sale
3.5
Zerillo Jeffrey

Senior VP Operations

Officer
1,207 -2.7%
54.99
US$66,373 		1,207 -2.7% 54.99 US$66,373
2026-05-06 2026-05-05 S Sale
3.5
Zerillo Jeffrey

Senior VP Operations

Officer
346 -0.8%
55.32
US$19,141 		346 -0.8% 55.32 US$19,141
2026-05-05 2026-05-05 PrS Proposed sale
3.5
Zerillo Jeffrey

Officer

Officer
346
55.32
US$19,141 		346 55.32 US$19,141
2026-02-13 2026-02-11 S Sale
3.5
Zerillo Jeffrey

Senior VP Operations

Officer
1,000 -2.4%
65.93
US$65,930 		1,000 -2.4% 65.93 US$65,930
2026-02-11 2026-02-11 PrS Proposed sale
3.5
Zerillo Jeffrey

Officer

Officer
1,000
65.93
US$65,930 		1,000 65.93 US$65,930
2025-12-02 2025-12-01 S Sale
3.5
Zerillo Jeffrey

Senior VP Operations

Officer
281 -0.7%
60.00
US$16,860 		281 -0.7% 60.00 US$16,860
2025-12-01 2025-12-01 PrS Proposed sale
3.5
Zerillo Jeffrey

Officer

Officer
281
60.00
US$16,860 		281 60.00 US$16,860
2025-12-02 2025-11-28 S Sale
3.5
Zerillo Jeffrey

Senior VP Operations

Officer
719 -1.7%
60.00
US$43,140 		719 -1.7% 60.00 US$43,140
2025-11-28 2025-11-28 PrS Proposed sale
3.5
Zerillo Jeffrey

Officer

Officer
719
60.00
US$43,140 		719 60.00 US$43,140
2025-11-26 2025-11-25 S Sale
0.9
BYOM JOHN E
Non-Executive Director
3,000 -5.5%
59.35
US$178,050 		3,000 -5.5% 59.35 US$178,050
2025-11-25 2025-11-25 PrS Proposed sale
0.9
BYOM JOHN E

Director

Non-Executive Director
3,000
59.35
US$178,050 		3,000 59.35 US$178,050
2025-03-12 2025-03-10 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
1,678 -8.9%
90.00
US$151,020 		1,678 -8.9% 90.00 US$151,020
2025-03-10 2025-03-10 PrS Proposed sale
2.8
Fritz Mary Beth

Officer

Officer
1,678
90.00
US$151,020 		1,678 90.00 US$151,020
2025-03-05 2025-03-03 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
6,297 -25.1%
85.39
US$537,701 		6,297 -25.1% 85.39 US$537,701
2025-03-03 2025-03-03 PrS Proposed sale
2.8
Fritz Mary Beth

Officer

Officer
6,297
85.39
US$537,725 		6,297 85.39 US$537,725
2025-02-13 2025-02-11 S Sale
2.9
Mekhail Adel

EVP, Marketing & Sales

Officer
5,683 -23.6%
86.30
US$490,443 		5,683 -23.6% 86.30 US$490,443
2025-02-13 2025-02-11 S Sale
2.9
Mekhail Adel

EVP, Marketing & Sales

Officer
5,400 -22.7%
86.82
US$468,828 		5,400 -22.7% 86.82 US$468,828
2025-02-11 2025-02-11 PrS Proposed sale
2.9
Mekhail Adel

Officer

Officer
11,083
86.21
US$955,509 		11,083 86.21 US$955,509
2024-11-21 2024-11-19 S Sale
3.3
Lombardi Ronald M.

Chief Executive Officer

Executive Director
5,662 -1.7%
82.64
US$467,908 		5,662 -1.7% 82.64 US$467,908
2024-11-21 2024-11-19 S Sale
3.3
Lombardi Ronald M.

Chief Executive Officer

Executive Director
5,213 -1.6%
82.55
US$430,333 		5,213 -1.6% 82.55 US$430,333
2024-11-19 2024-11-19 PrS Proposed sale
3.3
Lombardi Ronald M.

Officer; Director

Executive Director
10,875
81.58
US$887,187 		10,875 81.58 US$887,187
2024-11-19 2024-11-18 S Sale
3.3
Lombardi Ronald M.

Chief Executive Officer

Executive Director
33,725 -9.5%
82.41
US$2,779,277 		33,725 -9.5% 82.41 US$2,779,277
2024-11-19 2024-11-18 S Sale
3.3
Lombardi Ronald M.

Chief Executive Officer

Executive Director
48,512 -13.1%
82.67
US$4,010,487 		48,512 -13.1% 82.67 US$4,010,487
2024-11-18 2024-11-18 PrS Proposed sale
3.3
Lombardi Ronald M.

Officer; Director

Executive Director
82,237
81.76
US$6,723,553 		82,237 81.76 US$6,723,553
2024-11-14 2024-11-12 S Sale
2.4
P'Pool William

See Remarks

Officer
8,987 -30.9%
81.85
US$735,586 		8,987 -30.9% 81.85 US$735,586
2024-11-14 2024-11-12 S Sale
2.9
Mekhail Adel

EVP, Marketing & Sales

Officer
9,063 -33.0%
82.00
US$743,166 		9,063 -33.0% 82.00 US$743,166
2024-11-14 2024-11-12 S Sale
2.6
Sacco Christine

Chief Financial Officer

Officer
24,686 -45.0%
82.01
US$2,024,499 		24,686 -45.0% 82.01 US$2,024,499
2024-11-14 2024-11-12 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
3,414 -15.3%
81.93
US$279,709 		3,414 -15.3% 81.93 US$279,709
2024-11-14 2024-11-12 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
6,471 -25.6%
81.99
US$530,557 		6,471 -25.6% 81.99 US$530,557
2024-11-12 2024-11-12 PrS Proposed sale
2.4
P'Pool William

Officer

Officer
8,987
81.85
US$735,612 		8,987 81.85 US$735,612
2024-11-12 2024-11-12 PrS Proposed sale
2.6
Sacco Christine

Officer

Officer
24,686
82.01
US$2,024,538 		24,686 82.01 US$2,024,538
2024-11-12 2024-11-12 PrS Proposed sale
2.8
Fritz Mary Beth

Officer

Officer
9,885
81.97
US$810,300 		9,885 81.97 US$810,300
2024-11-12 2024-11-12 PrS Proposed sale
2.9
Mekhail Adel

Officer

Officer
9,063
82.00
US$743,135 		9,063 82.00 US$743,135
2024-03-05 2024-03-01 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
110 -0.7%
70.41
US$7,745 		110 -0.7% 70.41 US$7,745
2024-03-05 2024-03-01 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
62 -0.4%
70.43
US$4,367 		62 -0.4% 70.43 US$4,367
2024-03-01 2024-03-01 PrS Proposed sale
2.8
Fritz Mary Beth

Officer

Officer
172
70.25
US$12,083 		172 70.25 US$12,083
2024-02-29 2024-02-28 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
416 -2.5%
70.36
US$29,270 		416 -2.5% 70.36 US$29,270
2024-02-29 2024-02-28 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
246 -1.5%
70.19
US$17,267 		246 -1.5% 70.19 US$17,267
2024-02-28 2024-02-28 PrS Proposed sale
2.8
Fritz Mary Beth

Officer

Officer
662
70.12
US$46,416 		662 70.12 US$46,416
2024-02-29 2024-02-27 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
1 -0.0%
70.00
US$70 		1 -0.0% 70.00 US$70
2024-02-27 2024-02-27 PrS Proposed sale
2.8
Fritz Mary Beth

Officer

Officer
1
70.00
US$70 		1 70.00 US$70
2024-02-27 2024-02-26 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
4,545 -22.2%
70.44
US$320,150 		4,545 -22.2% 70.44 US$320,150
2024-02-27 2024-02-26 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
5,132 -24.4%
70.43
US$361,447 		5,132 -24.4% 70.43 US$361,447
2024-02-26 2024-02-26 PrS Proposed sale
2.8
Fritz Mary Beth

Officer

Officer
9,677
70.17
US$678,998 		9,677 70.17 US$678,998
2024-02-27 2024-02-23 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
11 -0.1%
70.00
US$770 		11 -0.1% 70.00 US$770
2024-02-27 2024-02-23 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
12 -0.1%
70.00
US$840 		12 -0.1% 70.00 US$840
2024-02-23 2024-02-23 PrS Proposed sale
2.8
Fritz Mary Beth

Officer

Officer
23
70.00
US$1,610 		23 70.00 US$1,610
2024-02-20 2024-02-15 S Sale
2.9
Mekhail Adel

EVP, Marketing & Sales

Officer
11,549 -38.2%
69.08
US$797,805 		11,549 -38.2% 69.08 US$797,805
2024-02-20 2024-02-15 S Sale
2.9
Mekhail Adel

EVP, Marketing & Sales

Officer
4,000 -17.6%
69.21
US$276,840 		4,000 -17.6% 69.21 US$276,840
2024-02-15 2024-02-15 PrS Proposed sale
2.9
Mekhail Adel

Officer

Officer
15,549
69.01
US$1,073,080 		15,549 69.01 US$1,073,080
2024-02-16 2024-02-14 S Sale
2.4
P'Pool William

See remarks

Officer
13,683 -35.4%
67.79
US$927,571 		13,683 -35.4% 67.79 US$927,571
2024-02-16 2024-02-14 S Sale
2.4
P'Pool William

See remarks

Officer
12,336 -33.1%
68.02
US$839,095 		12,336 -33.1% 68.02 US$839,095
2024-02-16 2024-02-14 S Sale
2.6
Sacco Christine

Chief Financial Officer

Officer
24,788 -53.3%
68.41
US$1,695,747 		24,788 -53.3% 68.41 US$1,695,747
2024-02-16 2024-02-14 S Sale
2.6
Sacco Christine

Chief Financial Officer

Officer
5,231 -17.5%
68.08
US$356,126 		5,231 -17.5% 68.08 US$356,126
2024-02-14 2024-02-14 PrS Proposed sale
2.6
Sacco Christine

Officer

Officer
30,019
67.99
US$2,041,064 		30,019 67.99 US$2,041,064
2024-02-14 2024-02-14 PrS Proposed sale
2.4
P'Pool William

Officer

Officer
26,019
67.61
US$1,759,192 		26,019 67.61 US$1,759,192
2024-02-12 2024-02-08 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
5,336 -25.1%
69.00
US$368,184 		5,336 -25.1% 69.00 US$368,184
2024-02-08 2024-02-08 PrS Proposed sale
2.8
Fritz Mary Beth

Officer

Officer
5,336
68.09
US$363,352 		5,336 68.09 US$363,352
2023-09-15 2023-09-14 S Sale
2.8
Fritz Mary Beth

SVP Quality & Regulatory

Officer
2,540 -13.7%
58.92
US$149,657 		2,540 -13.7% 58.92 US$149,657
2023-09-14 2023-09-14 PrS Proposed sale
2.8
Fritz Mary Beth

Officer

Officer
254
589.20
US$149,657 		254 589.20 US$149,657
2023-08-09 2023-08-08 S Sale
3.3
Lombardi Ronald M.

Chief Executive Officer

Executive Director
1,891 -0.7%
67.95
US$128,493 		1,891 -0.7% 67.95 US$128,493
2023-08-09 2023-08-08 S Sale
3.3
Lombardi Ronald M.

Chief Executive Officer

Executive Director
5,052 -1.8%
66.99
US$338,433 		5,052 -1.8% 66.99 US$338,433
2023-08-09 2023-08-08 S Sale
3.3
Lombardi Ronald M.

Chief Executive Officer

Executive Director
3,608 -1.3%
65.99
US$238,092 		3,608 -1.3% 65.99 US$238,092
2023-08-09 2023-08-08 S Sale
3.3
Lombardi Ronald M.

Chief Executive Officer

Executive Director
22,249 -7.3%
64.97
US$1,445,518 		22,249 -7.3% 64.97 US$1,445,518
2023-08-08 2023-08-08 PrS Proposed sale
3.3
Lombardi Ronald M.

Officer; Director

Executive Director
32,800
68.20
US$2,236,960 		32,800 68.20 US$2,236,960
2023-05-26 2023-05-24 S Sale
2.6
Sacco Christine

Chief Financial Officer

Officer
18,265 -40.4%
60.07
US$1,097,179 		18,265 -40.4% 60.07 US$1,097,179
2023-05-26 2023-05-24 S Sale
2.6
Sacco Christine

Chief Financial Officer

Officer
25,746 -36.3%
60.07
US$1,546,562 		25,746 -36.3% 60.07 US$1,546,562
2023-05-26 2023-05-24 S Sale
2.6
Sacco Christine

Chief Financial Officer

Officer
11,283 -20.0%
60.07
US$677,770 		11,283 -20.0% 60.07 US$677,770
2023-05-24 2023-05-24 PrS Proposed sale
2.6
Sacco Christine

Officer

Officer
55,294
59.39
US$3,283,714 		55,294 59.39 US$3,283,714
2023-05-22 2023-05-19 S Sale
2.9
Mekhail Adel

EVP, Marketing & Sales

Officer
7,194 -27.8%
65.65
US$472,286 		7,194 -27.8% 65.65 US$472,286
Explore more

More insider trading research around Prestige Consumer Healthcare Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America